Raising a $30M Fund 1 to Combat Cancer with Ben Freeberg of Oncology Ventures

Dec 17, 2024

Neil Devani

This week on Money Moves, Neil chats with Ben Freeberg, the founder of Oncology Ventures, a venture fund dedicated to driving innovation in the oncology space. They discuss Ben’s journey from cancer survivor to founder, exploring his personal motivations, industry insights, and the challenges of building a specialized fund. 

Ben shares his unique approach to identifying and investing in groundbreaking startups that aim to improve cancer care and research, offering invaluable advice for founders and first-time fund managers.

This episode also highlights the mechanics of fundraising, including Ben’s experience closing an oversubscribed $30 million fund, strategies for building a compelling pitch, and navigating the complexities of the healthcare industry. This episode offers an inspiring and educational deep dive into the world of oncology-focused innovation.


Topics Discussed in the Episode:

  • Ben’s journey from cancer survivor to founding Oncology Ventures.

  • Strategies for pitching to VCs and understanding what investors want.

  • The nuances of fundraising as a solo GP in a specialized sector.

  • The importance of building a strong network in the venture capital ecosystem.

  • Tips for founders on preparing for commercialization and market entry.


Connect with Ben Freeberg

This week on Money Moves, Neil chats with Ben Freeberg, the founder of Oncology Ventures, a venture fund dedicated to driving innovation in the oncology space. They discuss Ben’s journey from cancer survivor to founder, exploring his personal motivations, industry insights, and the challenges of building a specialized fund. 

Ben shares his unique approach to identifying and investing in groundbreaking startups that aim to improve cancer care and research, offering invaluable advice for founders and first-time fund managers.

This episode also highlights the mechanics of fundraising, including Ben’s experience closing an oversubscribed $30 million fund, strategies for building a compelling pitch, and navigating the complexities of the healthcare industry. This episode offers an inspiring and educational deep dive into the world of oncology-focused innovation.


Topics Discussed in the Episode:

  • Ben’s journey from cancer survivor to founding Oncology Ventures.

  • Strategies for pitching to VCs and understanding what investors want.

  • The nuances of fundraising as a solo GP in a specialized sector.

  • The importance of building a strong network in the venture capital ecosystem.

  • Tips for founders on preparing for commercialization and market entry.


Connect with Ben Freeberg

This week on Money Moves, Neil chats with Ben Freeberg, the founder of Oncology Ventures, a venture fund dedicated to driving innovation in the oncology space. They discuss Ben’s journey from cancer survivor to founder, exploring his personal motivations, industry insights, and the challenges of building a specialized fund. 

Ben shares his unique approach to identifying and investing in groundbreaking startups that aim to improve cancer care and research, offering invaluable advice for founders and first-time fund managers.

This episode also highlights the mechanics of fundraising, including Ben’s experience closing an oversubscribed $30 million fund, strategies for building a compelling pitch, and navigating the complexities of the healthcare industry. This episode offers an inspiring and educational deep dive into the world of oncology-focused innovation.


Topics Discussed in the Episode:

  • Ben’s journey from cancer survivor to founding Oncology Ventures.

  • Strategies for pitching to VCs and understanding what investors want.

  • The nuances of fundraising as a solo GP in a specialized sector.

  • The importance of building a strong network in the venture capital ecosystem.

  • Tips for founders on preparing for commercialization and market entry.


Connect with Ben Freeberg

Sign up for exclusive, insider info on pre-seed, emerging tech, and venture investing

©Necessary Ventures 2025

Sign up for exclusive, insider info on pre-seed, emerging tech, and venture investing

©Necessary Ventures 2025

Sign up for exclusive, insider info on pre-seed, emerging tech, and venture investing

©Necessary Ventures 2025

Sign up for exclusive, insider info on pre-seed, emerging tech, and venture investing

©Necessary Ventures 2025